Myron Z. Holubiak
Director, Adhera Therapeutics, Inc.
Companies
- CITIUS ONCOLOGY, INC.Secretary Dec 16, 2024 to now1
- CITIUS ONCOLOGY, INC.Board member Aug 14, 2024 to now2
- Citius Pharmaceuticals, Inc.Vice chair Oct 6, 2022 to now3
- Citius Pharmaceuticals, Inc.Board member Oct 27, 2015 to now4
- Citius Pharmaceuticals, Inc.Chief executive officer Apr 8, 2016 to Oct 13, 20215
- Citius Pharmaceuticals, Inc.President Apr 8, 2016 to Oct 13, 20215
- ASSEMBLY BIOSCIENCES, INC.Board member Dec 15, 2010 to May 24, 20216
- Option Care Health, Inc.Board member May 25, 2006 to Jun 2, 20167
- Adhera Therapeutics, Inc.Board member Jun 15, 2006 to Aug 16, 20078
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CITIUS ONCOLOGY, INC. CTOR950,000 shares9$671.6K at $0.71Sep 19, 2025
- Citius Pharmaceuticals, Inc. CTXR79,690 shares10$33.8K at $0.42Aug 12, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 19, 2025Granted 100,000 shares of CITIUS ONCOLOGY, INC.11
- Sep 19, 2025Granted 850,000 shares of CITIUS ONCOLOGY, INC.11
- Sep 19, 2025Granted 850,000 shares of CITIUS ONCOLOGY, INC.9
- Sep 19, 2025Granted 850,000 shares of CITIUS ONCOLOGY, INC.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCITIUS ONCOLOGY, INC., Secretary
- 2SEC EDGARCITIUS ONCOLOGY, INC., Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Sep 23, 2025
- 12SEC EDGARForm 4 filed Dec 1, 2025